Results 21 to 30 of about 1,127,916 (265)

Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer Patients With Different Metastatic Sites: A Systematic Review and Meta-Analysis

Frontiers in Oncology, 2020
Background: Organ-specific response patterns reported in previous studies indicate different response toward immune checkpoint inhibitors (ICIs) in non-small-cell lung cancer (NSCLC) patients with different metastatic sites.
Kaili Yang, Jiarui Li, Chunmei Bai, Zhao Sun, Lin Zhao   +4 more
doaj   +1 more source

Factors in perioperative care that determine blood loss in liver surgery [PDF]

, 2012
Excessive blood loss during liver surgery contributes to postoperative morbidity and mortality and the minimizing of blood loss improves outcomes. This study examines pre- and intraoperative factors contributing to blood loss and identifies areas for ...
McNally, Stephen J, McKeown, Dermot W, Parks, Rowan W; id_orcid, Garden, O. James, Parks, Rowan W., Revie, Erica J, Revie, Erica J., Garden, O James, McKeown, Dermot W., Massie, Lisa J, McNally, Stephen J., Wigmore, Stephen J, Wigmore, Stephen J., Massie, Lisa J.   +13 more
core   +1 more source

68Ga-PSMA-PET/CT for the evaluation of liver metastases in patients with prostate cancer

Cancer Imaging, 2019
Background The purpose of this study was to evaluate the imaging properties of hepatic metastases in 68Ga-PSMA positron emission tomography (PET) in patients with prostate cancer (PC).
Jonathan Damjanovic, Jan-Carlo Janssen, Vikas Prasad, Gerd Diederichs, Thula Walter, Winfried Brenner, Marcus R. Makowski   +6 more
doaj   +1 more source

Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases

, 2023
Background The role of recurrence-free survival (RFS) as a valid surrogate endpoint for overall survival (OS) in patients who underwent upfront surgery for colorectal liver metastases remains uncertain.
Takeuchi, J, Joint Comm Liver Metastases Survey, [missing], Kataoka, K, Ito, K, Kanemitsu, Y, Hasegawa, K, Ajioka, Y, Endo, I, Beppu, N, Ceelen, Wim, Ikeda, M, Takahashi, K   +11 more
core   +1 more source

The varied clonal trajectory of liver and lung metastases of colorectal cancer

Advances in Cancer Biology - Metastasis
Background: The liver and lungs are the most common sites of colorectal cancer (CRC) metastases. Their involvement can take five different clinical scenarios: lung metastases only, liver metastases only, lung metastases before liver metastases, liver ...
Ofer N. Gofrit, Ben Gofrit, S. Nahum Goldberg, Aron Popovtzer, Jacob Sosna, Ayala Hubert   +5 more
doaj   +1 more source

Identifying CT-Based Risk Factors Associated with Synchronous Liver Metastases in Colorectal Cancer

대한영상의학회지, 2017
Purpose: The aim of this study was to determine the radiologic risk factors of colorectal cancer (CRC) with synchronous liver metastases. Materials and Methods: A total of 197 patients with CRC who had a visible tumor on contrast-enhanced ...
Cho Rong Seo, Seung Joon Choi, Hyung Sik Kim   +2 more
doaj   +1 more source

Angiopoietin-2 blockade suppresses growth of liver metastases from pancreatic neuroendocrine tumors by promoting T cell recruitment

The Journal of Clinical Investigation, 2023
Improving the management of metastasis in pancreatic neuroendocrine tumors (PanNETs) is critical, as nearly half of patients with PanNETs present with liver metastases, and this accounts for the majority of patient mortality. We identified angiopoietin-2
Eunhyeong Lee, Sophie O’Keefe, Alessandra Leong, Ha-Ram Park, Janani Varadarajan, Subrata Chowdhury, Shannon Hiner, Sungsoo Kim, Anahita Shiva, Richard A. Friedman, Helen Remotti, Tito Fojo, Hee Won Yang, Gavin Thurston, Minah Kim   +14 more
doaj   +1 more source

Radiofrequency Ablation for Colorectal Cancer Liver Metastases: Outcomes and Prognostic Factors Associated with Survival

, 2023
Background: To determine the long-term outcomes of radiofrequency ablation with respect to overall survival, disease-free survival, and complications in patients with colorectal cancer liver metastases.
Okan Akhan, Türkmen Çiftçi, Devrim Akıncı, ÇİFTÇİ, Türkmen Turan, Emre Ünal, ÜNAL, EMRE, METİN, Yavuz, Seray Akçalar, AKINCI, Devrim, AKHAN, Okan, Akçalar, Seray, Yavuz Metin   +11 more
core   +1 more source

The impact of pulmonary metastasectomy in patients with previously resected colorectal cancer liver metastases. [PDF]

PLoS ONE, 2017
BACKGROUND:40-50% of patients with colorectal cancer (CRC) will develop liver metastases (CRLM) during the course of the disease. One third of these patients will additionally develop pulmonary metastases. METHODS:137 consecutive patients with CRLM, were
Armin Wiegering, Johannes Riegel, Johanna Wagner, Volker Kunzmann, Johannes Baur, Thorsten Walles, Ulrich Dietz, Stefan Loeb, Christoph-Thomas Germer, Ulrich Steger, Ingo Klein   +10 more
doaj   +1 more source

Percutaneous microwave ablation of disappearing colorectal liver metastases using US-MR fusion imaging guidance with integration of pre-chemotherapy imaging: A case report

Current Problems in Cancer: Case Reports, 2022
Liver metastases that disappear after chemotherapy are called vanishing or disappearing liver metastases. These metastases represent a diagnostic and clinical challenge as their biological behaviour is hardly predictable and their treatment is not ...
Arianna Nivolli, Emanuele Barabino, Francesca Lacelli, Matteo Arnò, Diego Ivald, Giulia Pittaluga, Andrea Percivale, Paolo Gazzo   +7 more
doaj   +1 more source